Roche Holding AG $RHHBY Shares Sold by Kornitzer Capital Management Inc. KS

Kornitzer Capital Management Inc. KS trimmed its holdings in shares of Roche Holding AG (OTCMKTS:RHHBY) by 28.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 65,118 shares of the company’s stock after selling 25,821 shares during the period. Kornitzer Capital Management Inc. KS’s holdings in Roche were worth $2,642,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Accent Capital Management LLC bought a new stake in shares of Roche during the 1st quarter valued at about $35,000. Atlas Capital Advisors Inc. acquired a new position in Roche in the first quarter valued at approximately $140,000. Beck Mack & Oliver LLC bought a new position in shares of Roche during the first quarter valued at approximately $232,000. Everett Harris & Co. CA acquired a new stake in shares of Roche during the 1st quarter worth approximately $445,000. Finally, FCA Corp TX bought a new stake in shares of Roche in the 1st quarter worth approximately $494,000.

Roche Stock Performance

Shares of OTCMKTS RHHBY opened at $42.27 on Monday. The firm’s 50-day simple moving average is $42.41 and its 200 day simple moving average is $40.70. Roche Holding AG has a fifty-two week low of $34.10 and a fifty-two week high of $45.94.

Analyst Ratings Changes

A number of brokerages recently commented on RHHBY. HSBC upgraded Roche from a “hold” rating to a “buy” rating and set a $50.00 price objective for the company in a research note on Thursday, October 2nd. Hsbc Global Res raised shares of Roche from a “hold” rating to a “strong-buy” rating in a report on Thursday, October 2nd. Three investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, Roche presently has a consensus rating of “Buy” and an average target price of $50.00.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.